Loading clinical trials...
Loading clinical trials...
The study will evaluate the effects of the direct renin inhibitor, aliskiren, on flow-mediated dilation of the brachial artery and on central aortic pressure in diabetic patients with pre-hypertension...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Alabama at Birmingham
Collaborators
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT06647511 · Gestational Hypertension
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT07224321 · Type 1 Diabetes Mellitus
NCT07439939 · Liver Cirrhosis, Portal Hypertension
UAB
Birmingham, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions